Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma Patients
Clinical trial NCT03870412 · UNKNOWN
Trial details
- NCT number
- NCT03870412
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2021-03-22
- Enrollment
- 485
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.